In This Article:
The Hong Kong market has shown resilience amid global economic uncertainties, with the Hang Seng Index recently posting a 1.99% gain. As investors navigate these fluctuating conditions, dividend stocks yielding over 6% can offer a reliable income stream and potential portfolio stability.
Top 10 Dividend Stocks In Hong Kong
Name | Dividend Yield | Dividend Rating |
Luk Fook Holdings (International) (SEHK:590) | 9.54% | ★★★★★☆ |
China Construction Bank (SEHK:939) | 7.65% | ★★★★★☆ |
China Electronics Huada Technology (SEHK:85) | 9.81% | ★★★★★☆ |
S.A.S. Dragon Holdings (SEHK:1184) | 9.11% | ★★★★★☆ |
Chongqing Rural Commercial Bank (SEHK:3618) | 8.00% | ★★★★★☆ |
Zhongsheng Group Holdings (SEHK:881) | 8.65% | ★★★★★☆ |
Bank of China (SEHK:3988) | 7.20% | ★★★★★☆ |
Zhejiang Expressway (SEHK:576) | 6.58% | ★★★★★☆ |
Sinopharm Group (SEHK:1099) | 4.87% | ★★★★★☆ |
Beijing Tong Ren Tang Chinese Medicine (SEHK:3613) | 3.77% | ★★★★★☆ |
Click here to see the full list of 83 stocks from our Top SEHK Dividend Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Bank of China
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Bank of China Limited, with a market cap of HK$1.44 trillion, offers a range of banking and financial services across Mainland China, Hong Kong, Macao, Taiwan, and internationally through its subsidiaries.
Operations: The revenue segments for Bank of China Limited encompass various banking and financial services provided across Mainland China, Hong Kong, Macao, Taiwan, and internationally.
Dividend Yield: 7.2%
Bank of China offers a stable dividend with a current yield of 7.2%, though it is lower than the top 25% in Hong Kong. The payout ratio is low at 32.6%, indicating dividends are well covered by earnings and forecasted to remain sustainable over the next three years. Recent board approvals for preferred dividend distributions and numerous fixed-income offerings, including $800 million in senior unsecured notes, reflect ongoing financial stability and liquidity management.
-
Navigate through the intricacies of Bank of China with our comprehensive dividend report here.
-
Our valuation report here indicates Bank of China may be undervalued.
China Medical System Holdings
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: China Medical System Holdings Limited is an investment holding company that manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China with a market cap of HK$17.56 billion.
Operations: China Medical System Holdings Limited generates CN¥7.01 billion in revenue from the marketing, promotion, sales, and manufacturing of pharmaceutical products in the People’s Republic of China.